Chemify Ltd
Chemify digitizes molecule design and production to let researchers design, synthesize, and iterate on compounds faster and more reproducibly. It does this with its Chemputation platform that combines automated robotics, a chemical programming language, and AI-driven design to execute programmable synthesis and closed-loop make-test cycles. The product is a deep-tech B2B platform integrating lab automation hardware with software for molecular design, synthesis execution, and data-driven optimization. Chemify primarily serves pharmaceutical, biotechnology, and industrial materials customers seeking to accelerate discovery and scale reproducible chemical synthesis.
Chemify Ltd
Chemify digitizes molecule design and production to let researchers design, synthesize, and iterate on compounds faster and more reproducibly. It does this with its Chemputation platform that combines automated robotics, a chemical programming language, and AI-driven design to execute programmable synthesis and closed-loop make-test cycles. The product is a deep-tech B2B platform integrating lab automation hardware with software for molecular design, synthesis execution, and data-driven optimization. Chemify primarily serves pharmaceutical, biotechnology, and industrial materials customers seeking to accelerate discovery and scale reproducible chemical synthesis.
TL;DR
Founded: 2019
Headquarters: Glasgow, United Kingdom
Core product: Chemputation: programmable chemistry platform combining chemical programming language, robotics, and AI
Primary customers: Pharmaceutical, biotechnology, and industrial materials companies
Reported total funding: USD 97,389,817
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Speeding and scaling molecular discovery and reproducible chemical synthesis through lab automation and software-driven workflows.
Founded
2019
Industry
Chemical Manufacturing
Tech Stack
Funding Track Record
Reported Series A lead
Reported seed round
Reported grant announcement
Investor Signal
“Backed by a mix of venture capital firms and philanthropic funders including Wing Venture Capital, Insight Partners, Triatomic Capital, BlueYard Capital, 8VC, Horizons Ventures, Rocketship.vc, DCVC, Founders Fund, and the Bill & Melinda Gates Foundation”